03:00 Tue 03 May 2016
Venture Life Group - First distribution agreements signed for UltraDEX
("
First distribution agreements signed for UltraDEX range
Bracknell,
The Company has signed exclusive five year distribution agreements with Laboratorios Serra Pamies, S.A ("
Shanghai Rifto is a specialist dental sales company selling directly into the dental channel in
The UltraDEX products are already approved for distribution in the EU but the timing of the launch of UltraDEX in
These agreements reflect the strong interest being seen by
For further information please contact:
James Hunter, Chief Financial Officer
Freddy Crossley +44 (0) 20 7886 2500
Peter Steel
Duncan Monteith
Corporate Finance
Tom Salvesen
Corporate Broking
David Bick +44 (0)20 7929 5599
Brian Alexander
About Venture Life
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin. The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.
Through its manufacturing company, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
About UltraDEX
The UltraDEX range of premium products includes mouthwashes, which are alcohol-free, and toothpastes and the products are used to treat bad breath, remineralise and whiten teeth and kill bacteria which cause plaque, which can in turn lead to tooth decay and gum disease. Incorporating patent protected and licensed intellectual property, the UltraDEX® products, including UltraDEX® Sensitive Recalcifying & Whitening range, are regarded as being particularly effective at managing bad breath, as supported by clinical data evidencing efficacy.
This information is provided by RNS
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE